SRZNW Stock Price, Chart, Stats & News

Surrozen, Inc.
Save
100,197
Market cap
–
Current P/E
–
Forward P/E
SRZNW chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 84.56% |
Operating margin | -1210.58% |
Pretax margin | -6960.77% |
Net margin | -6960.77% |
Effective tax rate | – |
ROA | -245.15% |
ROE | 610.83% |
D/E | -0.04x |
Interest coverage ratio | – |
SRZNW valuation
P/E | – |
P/S | 62.15x |
P/B | -1.15x |
P/CF | -7.15x |
P/FCF | -7.12x |
P/OCF | -7.15x |
PEG | 0.01x |
EV multiple | -2.92x |
About
Surrozen, Inc. is a biotechnology company dedicated to identifying and advancing therapeutic candidates. Their core strategy involves precisely influencing the Wnt signaling pathway to promote the body's natural processes of tissue restoration and regeneration. To achieve this, Surrozen engineers antibodies that target specific tissues, aiming to activate the intrinsic repair systems of the body.
Similar securities
Based on sector and market capitalization
Report issue











